/UTMD

Utah Medical Products Inc

UTMD

$69.80USD↓-2.70%-1.94 today

MARKET CAP

222.2M

P/E (TTM)

20.7x

FWD P/E

—

DAY RANGE

$69 – $71

52W RANGE

$54

$76

AI Summary

Stalk

StalkMedium

UTMD remains in a Stage 2 advancing regime supported by higher highs and higher lows, but price is encountering resistance at the July highs under overbought conditions. Short-term EMAs have flattened and price is holding just above them, reducing immediate upside edge. We will defer new entries and wait for pullbacks into the rising 9-/21-EMA zone, with the 50-DMA providing structural support.

↑Quarterly dividend of $0.31 (+1.6% YoY) yields ~0.57%
↑Earnings yield ~25% indicates attractive valuation vs peers
↓Growth score is negative, suggesting weak expansion potential

Full analysis →

Min Company Value

AI View

Min Insiders / Ticker

Hide Automated (10b5-1)

Date Range

Insider Trades3 trades

Date↓	Side	Ticker↕	Insider↕	Role↕	Shares↕	Price↕	Mkt Cap↕	52W High↕	52W Low↕	Value↕	% Chg↕	Rule↕	AI View↕
May 28, 2026	Sell	UTMD	Brian Koopman	Principal Financial Officer	50	$66.27	$222.2M	-7.85%	+30.08%	$3.3K	-6.01%	—	Stalk
Sep 4, 2025	Sell	UTMD	Brian Koopman	Principal Financial Officer	50	$62.75	$222.2M	-7.85%	+30.08%	$3.1K	-5.67%	—	Stalk
Jul 18, 2024	Sell	UTMD	Brian Koopman	Principal Financial Officer	50	$71.61	$222.2M	-7.85%	+30.08%	$3.6K	-5.36%	—	Stalk